Latest Articles

Article Type

You have access
Simultaneously Integrated Boost Affects Survival in Locally Advanced p16-Negative Oropharyngeal Squamous Cell Carcinoma
FRANCESCA DE FELICE, DANIELA MUSIO, MARIA SERPONE, GIANMARCO VAVALLE, CLAUDIA MARCHETTI and VINCENZO TOMBOLINI

Anticancer Research December 2022, 42 (12) 5909-5915; DOI: https://doi.org/10.21873/anticanres.16100
You have access
Efficacy of Chemotherapy Plus Bevacizumab in Recurrent Glioblastoma Multiform: A Real-life Study
ALEXANDRE BEIGE, FRANÇOIS GHIRINGHELLI, JULIE LECUELLE, CAROLINE TRUNTZER, GILLES TRUC, JULIE VINCENT, WALID FARAH, FRANÇOIS BORSOTTI, IRINA MAZILU and SILVIA MIHAELA ILIE

Anticancer Research December 2022, 42 (12) 5847-5858; DOI: https://doi.org/10.21873/anticanres.16093
You have access
Clinical Benefit of Bevacizumab and Irinotecan (BEV+IRI) in Patients With Relapsed/Refractory Glioblastoma (r/rGBM) and its Potential Predictors
JI HYUN PARK, HYUN SEOK LEE, JIN WOO CHOI, SO DUG LIM, HYEON KANG KOH, KYUNG RAE CHO, JOON CHO, YOUNG-CHO KOH and SO YOUNG YOON

Anticancer Research December 2022, 42 (12) 6091-6098; DOI: https://doi.org/10.21873/anticanres.16121
You have access
Limited Oncological Benefits of Laparoscopic Total Gastrectomy With Splenectomy for Patients With Type 4 or Large Type 3 Gastric Cancer
MASAZUMI SAKAGUCHI, HISAHIRO HOSOGI, SHIGEO HISAMORI, YOSUKE KINJO, SEIICHIRO KANAYA and KAZUTAKA OBAMA

Anticancer Research December 2022, 42 (12) 5937-5944; DOI: https://doi.org/10.21873/anticanres.16103
You have access
Fibroblast Activation Protein and Tertiary Lymphoid Structure in Colorectal Cancer Recurrence
SHIMON HAYASE, NORIKATSU MIYOSHI, SHIKI FUJINO, MASAYOSHI YASUI, MASAYUKI OHUE, SOICHIRO MINAMI, SHINYA KATO, AYUMI NAGAE, YUKI SEKIDO, TSUYOSHI HATA, ATSUSHI HAMABE, TAKAYUKI OGINO, HIDEKAZU TAKAHASHI, MAMORU UEMURA, HIROFUMI YAMAMOTO, YUICHIRO DOKI and HIDETOSHI EGUCHI

Anticancer Research December 2022, 42 (12) 5897-5907; DOI: https://doi.org/10.21873/anticanres.16099
You have access
Effect of Secondary Prophylactic G-CSF on the Occurrence of Febrile Neutropenia in Breast Cancer
KANAKO SUZUKI, SHINSUKE SASADA, YURI KIMURA, AKIKO EMI, TAKAYUKI KADOYA and MORIHITO OKADA

Anticancer Research December 2022, 42 (12) 5945-5949; DOI: https://doi.org/10.21873/anticanres.16104
Open Access
In Vitro Anticancer Activity of the Light Stable Zinc Isotope (⁶⁴Zn) Compounds
PETER NOVAK, ALEXANDR BALAKIN and MAX TEMNIK

Anticancer Research December 2022, 42 (12) 5685-5698; DOI: https://doi.org/10.21873/anticanres.16077
You have access
Phase I CAR-T Clinical Trials Review
SHAUN BULSARA, MENGFEN WU and TAO WANG

Anticancer Research December 2022, 42 (12) 5673-5684; DOI: https://doi.org/10.21873/anticanres.16076
You have access
Clinical Outcome and Risk Factors of Chronic Radiation Proctitis Following Pelvic Radiation Therapy
CHAN-MUK IM, ICK-JOON CHO, HYUNG-JOO YU, BORA HAN, HYUNG-HOON OH, YOON-JIN SEO, KI-HYUN KIM, DAE-SEONG MYUNG, SUNG-BOM CHO, WAN-SIK LEE, TAEK-KEUN NAM and YOUNG-EUN JOO

Anticancer Research December 2022, 42 (12) 5951-5959; DOI: https://doi.org/10.21873/anticanres.16105
Open Access
A Machine Learning Approach Using PET/CT-based Radiomics for Prediction of PD-L1 Expression in Non-small Cell Lung Cancer
CHAE HONG LIM, YOUNG WHA KOH, SEUNG HYUP HYUN and SU JIN LEE

Anticancer Research December 2022, 42 (12) 5875-5884; DOI: https://doi.org/10.21873/anticanres.16096

Main menu

User menu

Search

Latest Articles

Pages